GENOSS
Monalisa
Brand
GENOSS
Category
HA Filler
Origin
Korea
Options
Ultra · Hard · Mild · Soft
Available options
Interested in ordering Monalisa? Send an enquiry and our team will follow up with availability and pricing.
Used in
Overview
Monalisa is a cross-linked hyaluronic acid dermal filler line from the South Korean manufacturer GENOSS Co., Ltd., produced with proprietary Hy-BRID cross-linking technology to create uniform, densely packed HA particles. The range comprises four grades - Soft, Mild, Hard and Ultra - differentiated by particle size (approximately 200 to 900 microns) and firmness for depths from tear-trough to structural contouring. It is a non-animal, fermentation-derived HA platform positioned for high viscoelasticity and durability.
How it works
The cross-linked HA gel adds volume and binds water to hydrate and support the treated plane. Soft (smallest particles) suits fine/superficial and tear-trough work, Mild adds mid-dermal volume, Hard addresses deeper wrinkles and sculpting, and Ultra (largest particles, highest G-prime) is used for strong structural lines; depth and indication scale directly with particle size and gel firmness.
Indications
- Tear troughs and fine/superficial lines (Soft)
- Cheek volume and perioral lines (Mild)
- Nasolabial folds and medium-to-deep wrinkles (Hard)
- Nose, chin and jawline sculpting/projection (Hard/Ultra)
- Strong structural facial lines and contouring (Ultra)
Key features
- Four grades (Soft/Mild/Hard/Ultra) by particle size (~200-900 um)
- Hy-BRID cross-linking for uniform, dense HA particles
- Approx. 24 mg/mL non-animal cross-linked HA
- Lidocaine in Ultra and select grades
- Positioned for high viscoelasticity and durability
Benefits
- Four-grade range covers tear-trough to structural contouring
- Particle-size grading enables precise depth matching
- Uniform dense particles support predictable lift and longevity
- HA reversibility supports correction and risk control
- GENOSS-manufactured platform suited to B2B enquiry-to-order
Composition
Cross-linked hyaluronic acid of non-animal (fermentation) origin at approximately 24 mg/mL, produced by Hy-BRID cross-linking with graded particle sizes; Ultra (and select grades) formulated with lidocaine.
Usage & handling
Sterile single-use prefilled syringes for practitioner use; select the grade to match particle size and injection depth, inject slowly and avoid intravascular placement and overcorrection. HA-based and therefore adjustable and dissolvable with hyaluronidase for correction. Store and handle per label.
For medical professionals. Product information is for reference and does not replace the manufacturer's instructions for use. Availability and regulatory status vary by region.